Loading...
Danaher Corporation
DHR•NYSE
Healthcare
Medical - Diagnostics & Research
$197.09
$-0.07(-0.04%)
Danaher Corporation (DHR) Financial Performance & Income Statement Overview
Review Danaher Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-0.06%
↓ 0.06%
Operating Income Growth
-6.52%
↓ 6.52%
Net Income Growth
-18.16%
↓ 18.16%
Operating Cash Flow Growth
-6.64%
↓ 6.64%
Operating Margin
18.39%
↑ 18.39%
Gross Margin
59.66%
↑ 59.66%
Net Profit Margin
14.21%
↑ 14.21%
ROE
6.69%
↑ 6.69%
ROIC
5.90%
↑ 5.90%
Danaher Corporation (DHR) Income Statement & Financial Overview
Review Danaher Corporation's (DHR) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $5.74B | $6.54B | $5.80B | $5.74B |
| Cost of Revenue | $2.23B | $2.65B | $2.40B | $2.31B |
| Gross Profit | $3.51B | $3.89B | $3.40B | $3.43B |
| Gross Profit Ratio | $0.61 | $0.59 | $0.59 | $0.60 |
| R&D Expenses | $379.00M | $442.00M | $383.00M | $391.00M |
| SG&A Expenses | $1.86B | $2.02B | $2.06B | $1.87B |
| Operating Expenses | $2.24B | $2.46B | $2.44B | $2.26B |
| Total Costs & Expenses | $4.47B | $5.11B | $4.84B | $4.58B |
| Interest Income | $6.00M | $14.00M | $4.00M | $39.00M |
| Interest Expense | $72.00M | $61.00M | $87.00M | $65.00M |
| Depreciation & Amortization | $591.00M | $546.00M | $591.00M | $580.00M |
| EBITDA | $1.79B | $1.97B | $1.66B | $1.75B |
| EBITDA Ratio | $0.31 | $0.30 | $0.29 | $0.30 |
| Operating Income | $1.27B | $1.43B | $958.00M | $1.17B |
| Operating Income Ratio | $0.22 | $0.22 | $0.17 | $0.20 |
| Other Income/Expenses (Net) | -$145.00M | -$110.00M | $19.00M | -$85.00M |
| Income Before Tax | $1.13B | $1.31B | $977.00M | $1.08B |
| Income Before Tax Ratio | $0.20 | $0.20 | $0.17 | $0.19 |
| Income Tax Expense | $175.00M | $229.00M | $159.00M | $176.00M |
| Net Income | $954.00M | $1.09B | $818.00M | $907.00M |
| Net Income Ratio | $0.17 | $0.17 | $0.14 | $0.16 |
| EPS | $1.33 | $1.50 | $1.13 | $1.23 |
| Diluted EPS | $1.32 | $1.49 | $1.12 | $1.22 |
| Weighted Avg Shares Outstanding | $716.30M | $731.00M | $723.00M | $737.60M |
| Weighted Avg Shares Outstanding (Diluted) | $720.80M | $737.20M | $729.40M | $742.40M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan